SCHEMBL7103008

SCHEMBL7103008

O=CCNCCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.57
GAA P10253 2/20 0.57
MAPT P10636 1/20 0.57
KCNH2 Q12809 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
ATM Q13315 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
NPC1 O15118 1/20 0.50
KDM1A O60341 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL11220425 0.92 SIGMAR1 (0.58) SIGMAR1GAAMAPTKCNH2CA12
SCHEMBL11956408 0.88 SIGMAR1 (0.69) SIGMAR1KCNH2
SCHEMBL16298101 0.86 SIGMAR1 (0.68) SIGMAR1L3MBTL1
SCHEMBL283735 0.81 SIGMAR1 (0.81) SIGMAR1GAAMAPTKCNH2CA12
SCHEMBL252240 0.81 KCNH2 (0.56) SIGMAR1GAAMAPTKCNH2ATM
SCHEMBL8655738 0.79 KCNH2 (0.55) SIGMAR1GAAMAPTKCNH2ATM
SCHEMBL12831697 0.79 TAAR1 (0.53) GAAMAPTCA12CA1CA2
Hydrochloric Acid SCHEMBL2236705 0.79 GAA (0.59) SIGMAR1GAAMAPTKCNH2ATM
Water SCHEMBL27458807 0.79 KCNH2 (0.55) SIGMAR1GAAMAPTKCNH2ATM
Hydrochloric Acid SCHEMBL5028920 0.79 SIGMAR1 (0.77) SIGMAR1GAAMAPTKCNH2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112645888-A One-pot synthesis method of praziquantel intermediate 厦门优孚利生物医药科技有限公司 2021-04-13 CN claimed
EP-1361212-A1 Peptide derivatives as antithrombotic agents AstraZeneca AB (SE) 2003-11-12 EP claimed
EP-0672658-B1 Antithrombotic agents ASTRAZENECA AB (SE) 2003-09-17 EP claimed
US-5914319-A Antithrombotic agents ELI LILLY AND COMPANY (US) 1999-06-22 US claimed
US-5726159-A PEPTIDE THROMBIN INHIBITORS ELI LILLY AND COMPANY (US) 1998-03-10 US claimed
US-5710130-A HETEROCYCLIC SYNTHETIC PEPTIDES ELI LILLY AND COMPANY (US) 1998-01-20 US claimed
US-5707966-A Antithrombotic agents ELI LILLY AND COMPANY (US) 1998-01-13 US claimed
US-5705487-A PEPTIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1998-01-06 US claimed
EP-0672658-A1 Antithrombotic agents ELI LILLY AND COMPANY (US) 1995-09-20 EP claimed
WO-1995023609-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1995-09-08 WO claimed
CN-112645888-A One-pot synthesis method of praziquantel intermediate 厦门优孚利生物医药科技有限公司 2021-04-13 CN disclosed
CN-112645888-A One-pot synthesis method of praziquantel intermediate 厦门优孚利生物医药科技有限公司 2021-04-13 CN disclosed
WO-2011023722-A1 NOVEL QUINOXALINONE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-03 WO disclosed
EP-1361212-A1 Peptide derivatives as antithrombotic agents AstraZeneca AB (SE) 2003-11-12 EP disclosed
EP-0672658-B1 Antithrombotic agents ASTRAZENECA AB (SE) 2003-09-17 EP disclosed
EP-0672658-A1 Antithrombotic agents ELI LILLY AND COMPANY (US) 1995-09-20 EP disclosed
WO-1995023609-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1995-09-08 WO disclosed
EP-0486478-A2 Renin-inhibiting peptides THE UPJOHN COMPANY (US) 1992-05-20 EP disclosed
US-4880781-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1989-11-14 US disclosed
EP-0173481-A2 Peptides THE UPJOHN COMPANY (US) 1986-03-05 EP disclosed